EUVIMEDEUVIMED entdecken
Crossref

Angioimmunoblastic T-Cell Lymphoma Diagnosed From Serous Effusion by Integration of Cytologic Features and Ancillary Studies

Jinnan Li, Xianglan Zhu, Xueqin Deng, Wenyan Zhang, Yong Jiang, Yin Wan, Jie Chen, Cong Li, Weiping Liu, Sha Zhao, Xueying Su

American Journal of Clinical Pathology · 2023

DOI: 10.1093/ajcp/aqac170 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Clinical Pathology, 2023. Verfasst von Jinnan Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Lymphoma, T-Cell, Peripheral, Epstein-Barr Virus Infections, Immunoblastic Lymphadenopathy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Clinical Research Incubation Project, West China Hospital, Sichuan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To explore the approach to the diagnosis of malignant serous effusion (SE) caused by angioimmunoblastic T-cell lymphoma (AITL).

Methods

The clinical, cytomorphologic, immunophenotypic, and molecular features of 6 patients were summarized.

Results

Clinically, SE caused by AITL was predominant in middle-aged and older male patients with multiple SEs and lymphadenopathy. Cytomorphology showed small to medium-sized, irregular lymphocytes with clear cytoplasm and mixed with various inflammatory cells and apoptosis. Hodgkin/Reed-Sternberg–like cells were detected in 2 of 6 cases. Furthermore, 2 patterns of cytomorphology were described for the first time. Flow cytometry revealed abnormal T-cell populations with loss of surface CD3 (3/4 cases) and CD7 (3/4 cases). In addition, B-cell populations lacking surface immunoglobulin (Ig) were identified in 2 of 4 cases. Immunocytochemical staining revealed expression of at least 2 T follicular helper markers. Epstein-Barr virus–encoded RNA (EBER)–positive cells were demonstrated in 4 of 5 cases. Clonal T-cell receptor γ chain rearrangement was detected in 6 cases, and 3 of them had concomitant clonal immunoglobulin gene rearrangement. Moreover, 2 cases revealed discrepant findings regarding IgH/Igκ rearrangements in cytohistologic correlation.

Conclusions

This study broadens the morphologic spectrum of malignant SE caused by AITL and provides diagnostic criteria in routine practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, T-Cell, PeripheralEpstein-Barr Virus InfectionsImmunoblastic LymphadenopathyMiddle AgedHumansMaleAgedHerpesvirus 4, HumanT-Lymphocytes

Stichwörter der Autor:innen

AITLAncillary studiesCytologic-histologic correlationCytologySerous effusion

Autor:innen und Institutionen

  • Department of Pathology, West China Hospital, Sichuan University, Chengdu, China.
  • Core Facilities of West China Hospital, Sichuan University, Chengdu, China.

Förderung

  • Clinical Research Incubation Project
  • West China Hospital, Sichuan University

Zitieren

APA

Li, J., Zhu, X., Deng, X., Zhang, W., Jiang, Y., Wan, Y., Chen, J., Li, C., Liu, W., Zhao, S., & Su, X. (2023). Angioimmunoblastic T-Cell Lymphoma Diagnosed From Serous Effusion by Integration of Cytologic Features and Ancillary Studies. American Journal of Clinical Pathology. https://doi.org/10.1093/ajcp/aqac170

Vancouver

Li J, Zhu X, Deng X, Zhang W, Jiang Y, Wan Y, et al. Angioimmunoblastic T-Cell Lymphoma Diagnosed From Serous Effusion by Integration of Cytologic Features and Ancillary Studies. American Journal of Clinical Pathology. 2023. doi:10.1093/ajcp/aqac170

BibTeX
@article{Li2023,
  author = {Li, Jinnan and Zhu, Xianglan and Deng, Xueqin and Zhang, Wenyan and Jiang, Yong and Wan, Yin and Chen, Jie and Li, Cong and Liu, Weiping and Zhao, Sha and Su, Xueying},
  title = {Angioimmunoblastic T-Cell Lymphoma Diagnosed From Serous Effusion by Integration of Cytologic Features and Ancillary Studies},
  journal = {American Journal of Clinical Pathology},
  year = {2023},
  doi = {10.1093/ajcp/aqac170}
}
Kostenlos starten →